polyethylene glycol 3350, sodium sulfate anhydrous, sodium bicarbonate, sodium chloride, potassium chloride
GOLYTELY (polyethylene glycol 3350, sodium sulfate anhydrous, sodium bicarbonate, sodium chloride, potassium chloride) by R-Pharm US is osmotic activity [moa]. First approved in 1984.
Drug data last refreshed 9h ago · AI intelligence enriched 11h ago
GOLYTELY is an oral osmotic laxative solution containing polyethylene glycol 3350 and electrolytes, designed for bowel cleansing prior to colonoscopy and other GI procedures. It works by drawing water into the intestinal lumen through osmotic activity, producing rapid evacuation without significant net fluid or electrolyte loss. The product is administered as a solution mixed from powder and is a standard-of-care bowel prep agent.
Mature product approaching loss of exclusivity with modest Medicare claims volume; brand maintenance teams will prioritize cost-efficiency and patient adherence over growth initiatives.
Osmotic Activity
Osmotic Laxative
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Comparison of Clenpiq vs Golytely Bowel Preparation
Miralax (PEG 3350) vs. Golytely as Bowel Preparation for Screening Colonoscopy
A Trial Comparing Bowel Preparation and Patient Tolerability of Miralax Versus Golytely
Amitiza® Plus GoLYTELY® (PEG) Versus Placebo Plus GoLYTELY® for Outpatient Colonoscopy Preparation
Split Dose Golytely With Amitiza Pretreatment Versus Split Dose Golytely Plus Placebo in Outpatient Colonoscopy
Worked on GOLYTELY at R-Pharm US? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/moWorking on GOLYTELY offers stability and deep expertise in a mature, essential procedure-prep category, but limited growth upside or clinical innovation exposure. Career value lies in mastering formulary dynamics, generic competition, cost-containment strategies, and patient adherence—skills transferable to other specialty care and OTC portfolios.